Avraham Molcho
Directeur/Bestuurslid bij BIOLINERX LTD.
Vermogen: - $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Avraham Molcho
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 33 | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies.
17
| Private Company | Investment Managers | 17 |
Ayana Pharma Ltd.
 Ayana Pharma Ltd. Pharmaceuticals: MajorHealth Technology Ayana Pharma Ltd. is an Israeli pharmaceutical company that specializes in developing liposomal therapeutics for cancer treatment. The company is based in Jerusalem, Israel. Ayana Pharma was founded in 2012 by Yechezkel Barenholz and Avraham Molcho, with Yechezkel Barenholz serving as the CEO since its inception.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Biolojic Design Ltd.
 Biolojic Design Ltd. Pharmaceuticals: MajorHealth Technology Biolojic Design Ltd. operates as a biopharmaceutical company. The company was founded by Avi Molcho, and Yanay Ofran in 2009 and is headquartered in Givat Shmuel, Israel.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Avraham Molcho via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree Masters Business Admin Graduate Degree Masters Business Admin Masters Business Admin Doctorate Degree Doctorate Degree | |
| Weizmann Institute of Science | College/University | Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Director/Board Member Director/Board Member Chief Operating Officer | |
| EVOGENE LTD. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| COMPUGEN LTD. | Biotechnology | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
| Bioline Innovations Jerusalem LP | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | ||
| York University | College/University | Undergraduate Degree Masters Business Admin | |
| UNIVO PHARMACEUTICALS LTD | Biotechnology | Chairman Director/Board Member | |
| Ben-Gurion University of the Negev | College/University | Doctorate Degree Masters Business Admin | |
Oxitope Pharma BV
 Oxitope Pharma BV Pharmaceuticals: MajorHealth Technology Oxitope Pharma BV is a Dutch pharmaceutical start-up founded in 2020 that focuses on discovering and developing medicine for the treatment of inflammatory and cardiovascular diseases caused by oxidative stress. The company is based in Naarden, Netherlands. The Dutch company takes a different approach to the diagnosis and treatment of these diseases by preventing, halting, or reversing acute and chronic diseases driven by oxidized phospholipids. Oxitope Pharma's goal is to enable people to live long and healthy lives. The CEO is John Montana. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| The College of Management Academic Studies | College/University | Undergraduate Degree Graduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
Brightman Almagor Zohar & Co.
 Brightman Almagor Zohar & Co. Miscellaneous Commercial ServicesCommercial Services Brightman Almagor Zohar & Co. provides auditing and accounting services to technology, media, telecommunication, real estate, and financial services sectors. The company offers budget control and cost accounting; business planning; transfer pricing; real estate taxation; and audit committee services. The company is headquartered in Tel Aviv, Israel. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Director/Board Member | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Toronto | College/University | Graduate Degree Undergraduate Degree | |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Chairman Chairman | |
Aulos Bioscience, Inc.
 Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| POLYPID LTD. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Groningen | College/University | Graduate Degree Graduate Degree | |
| Erasmus University Rotterdam | College/University | Masters Business Admin Graduate Degree | |
| Bar-Ilan University | College/University | Masters Business Admin Undergraduate Degree | |
| The Hebrew University Hadassah Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
NewAmsterdam Pharma BV
 NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Biotechnology | Chairman Director/Board Member | |
Hadasit Medical Research Services & Development Ltd.
 Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| SCOPUS BIOPHARMA INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ADVAXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Pennsylvania | College/University | Masters Business Admin | |
MOBILion Systems, Inc.
 MOBILion Systems, Inc. Packaged SoftwareTechnology Services MOBILion Systems, Inc. offers paradigm-shifting platform technology. It will Develop a cost effective analytical system with a small footprint, high throughput, ultra-high sensitivity and selectivity enabling use in commercial applications unattainable by conventional ion mobility separation devices. The company was founded in 2015 and is headquartered in , Chadds Ford, PA. | Packaged Software | Director/Board Member | |
aMoon Ventures Y Sh Ltd.
 aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures Y Sh Ltd (aMoon Ventures) is an venture capital firm founded in 2016 by Marius Nacht and Dr. Yair Schindel. The firm is headquartered in Israel. | Investment Managers | Private Equity Investor | |
Theranica Bio-Electronics Ltd.
 Theranica Bio-Electronics Ltd. Medical SpecialtiesHealth Technology Theranica Bio-Electronics Ltd. develops wearable medical devices. Its product is Nerivio Migra. The company was founded by Alon Ironi, Ronen Jashek, Rotislav Barabash, and Shimon Eckhouseand in 2016 and is headquartered in Netanya, Israel. | Medical Specialties | Director/Board Member | |
SMART Medical Systems Ltd.
 SMART Medical Systems Ltd. Medical SpecialtiesHealth Technology SMART Medical Systems Ltd. manufactures medical devices. The firm’s products include naviaid platform, G-EYE, naviaid AB, naviaid ABC, inflation systems, controlled withdrawal nd future naviaid products. The company was founded by Gadi Terliuc in 205 and is headquartered in Ra’anana, Israel. | Medical Specialties | Director/Board Member | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity | |
Pharmascience, Inc.
 Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Pharmascience, Inc. manufactures and distributes generic and drug products. It offers liquids, tablets, capsules, suppositories, powders, and ophthalmic. The company was founded by Morris Goodman and Ted S. Wise in 1983 and is headquartered in Montr?al, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Signet Healthcare Partners LLC
 Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners LLC (Signet Healthcare Partners) is a private equity/venture capital subsidiary of Sanders Morris Harris Group Private Equity founded in 1998. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Mercer Management Consulting, Inc.
 Mercer Management Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Mercer Management Consulting, Inc. provides management consulting services. The company offers business design innovation, brand strategy, operational excellence, transformation, and portfolio strategy services. The firm was founded in 1990 and is located in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Joddes Ltd.
 Joddes Ltd. Investment ManagersFinance Joddes Ltd. is a private company based in Hampstead, Canada. and has subsidiaries in Canada. The CEO of the Canadian company is Marc Pierre Martin Rouleau. | Investment Managers | Director/Board Member | |
Arbor Pharmaceuticals LLC
 Arbor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Arbor Pharmaceuticals LLC develops pharmaceutical products, which focuses on cardiovascular, hospital and pediatric markets. It offers edarbyclor, cetylev, horizant, zenzedi, evekeo, sklice, and eryhromycin. The company was founded by Jarrett T. Disbrow and Edward J. Schutter and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member | |
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman | |
| R&d Integrative Solutions | Corporate Officer/Principal | ||
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| International Rare Diseases Research Consortium | Corporate Officer/Principal |
Statistieken
Internationaal
| Israël | 28 |
| Verenigde Staten | 13 |
| Canada | 6 |
| Nederland | 5 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 14 |
| Finance | 8 |
| Commercial Services | 4 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 221 |
| Corporate Officer/Principal | 73 |
| Independent Dir/Board Member | 42 |
| Chairman | 41 |
| Undergraduate Degree | 39 |
Sterkste connecties
| Insiders | |
|---|---|
| Raf Hofstein | 36 |
| Michael Anghel | 32 |
| Aharon Schwartz | 29 |
| Gil Bianco | 23 |
| Todd Sone | 19 |
| Sandra Panem | 18 |
| Barbara-Jean Bormann-Kennedy | 16 |
| Nurit Benjamini | 15 |
| Kinneret Livnat-Savitsky | 15 |
| Carlo Incerti | 14 |
| Dirk Kersten | 14 |
| Christina Takke | 14 |
| Philip Astley-Sparke | 12 |
| Bart Bergstein | 12 |
| Rami Dar | 11 |
- Beurs
- Insiders
- Avraham Molcho
- Bedrijfsconnecties
